Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001445297 | SCV001648325 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001445297 | SCV001784214 | uncertain significance | not provided | 2021-06-23 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27535533) |
Mayo Clinic Laboratories, |
RCV001445297 | SCV005408713 | uncertain significance | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | BP4 |
Prevention |
RCV003946162 | SCV004758176 | likely benign | FDX2-related disorder | 2023-04-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |